{
  "version": "1.0",
  "risk_thresholds": {
    "ASCVD": { 
      "units": "percent", 
      "cutoffs": { "low": 7.5, "high": 20 }, 
      "labels": { 
        "low": "Low (<7.5%)", 
        "intermediate": "Intermediate (7.5–20%)", 
        "high": "High (>=20%)" 
      } 
    },
    "Framingham": { 
      "units": "percent", 
      "cutoffs": { "moderate": 10, "high": 20 } 
    },
    "FRAX_major": { 
      "units": "percent", 
      "cutoffs": { "moderate": 10, "high": 20 } 
    },
    "FRAX_hip": { 
      "units": "percent", 
      "cutoffs": { "high": 3 } 
    },
    "GAIL_5yr": { 
      "units": "percent", 
      "cutoffs": { "elevated_5yr": 1.7 } 
    },
    "WELLS_VTE": { 
      "units": "score", 
      "cutoffs": { "low": 0, "moderate": 2, "high": 3 } 
    }
  },
  "actions": {
    "ASCVD_high": [
      "Avoid estrogen-based HRT", 
      "Recommend non-hormonal alternatives", 
      "Cardiology review"
    ],
    "ASCVD_intermediate": [
      "Weigh risks/benefits of HRT", 
      "Consider cardiology consult"
    ],
    "FRAX_high": [
      "Initiate osteoporosis management", 
      "Prioritize bone-protection strategies"
    ],
    "GAIL_elevated": [
      "Breast risk specialist review", 
      "Exercise caution with combined HRT"
    ],
    "WELLS_high": [
      "Avoid estrogen-based therapy", 
      "Urgent VTE evaluation"
    ]
  },
  "defaults": {
    "insufficient_data": "Insufficient data — clinician review required"
  },
  "precedence": [
    "absolute_contraindications", 
    "interactions_high", 
    "risk_high", 
    "risk_moderate", 
    "symptom_guided"
  ]
}